The Big Question: Can Pharma Truly Be Remodelled with AI?
Join us as we explore the benefits and pitfalls of AI use in pharmaceutical contexts
Maryam Mahdi | | 2 min read | Technology
Perhaps the pharmaceutical industry’s relationship with artificial intelligence will continue to grow from strength to strength – taking science to hitherto unimagined places. Perhaps algorithms and machine learning platforms will be slowly, subtly, but irreversibly integrated into the world of medicine making…
We explore. Welcome to The Big Question – a new series for The Medicine Maker that takes an in-depth look at a hot topic. First up: artificial intelligence (AI).
But why? AI is often touted in pharma circles as a great enabler that could streamline manufacturing processes, cut out the noise in the mountains of data produced and obtained by pharmaceutical companies, and reduce the risk of error. To this end, more and more companies are beginning to explore how they can implement AI technologies.
Our experts had vastly different interpretations and thoughts on the topic. Can AI technologies really help drive the industry to new heights or does the hype outweigh reality? Let’s hear their views.